Stephens upgraded shares of Halyard Health, Inc. (NYSE:HYH) from an equal weight rating to an overweight rating in a research note released on Thursday morning.

A number of other equities research analysts also recently commented on the stock. TheStreet upgraded shares of Halyard Health from a c rating to a b- rating in a report on Thursday, April 6th. Zacks Investment Research upgraded shares of Halyard Health from a sell rating to a buy rating and set a $44.00 price target for the company in a report on Wednesday, May 3rd. Finally, BidaskClub upgraded shares of Halyard Health from a hold rating to a buy rating in a report on Wednesday, June 28th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of Buy and a consensus target price of $42.25.

Halyard Health (NYSE:HYH) traded up 0.28% during mid-day trading on Thursday, hitting $42.73. 122,164 shares of the stock traded hands. The firm’s 50-day moving average is $39.44 and its 200-day moving average is $38.58. Halyard Health has a 12-month low of $31.59 and a 12-month high of $42.81. The company has a market cap of $2.00 billion, a price-to-earnings ratio of 41.09 and a beta of 1.78.

Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.14. The business had revenue of $399.20 million during the quarter, compared to the consensus estimate of $399.16 million. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The company’s quarterly revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.45 earnings per share. Equities research analysts expect that Halyard Health will post $1.96 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Daily Political and is owned by of Daily Political. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/07/halyard-health-inc-hyh-upgraded-at-stephens.html.

Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its position in Halyard Health by 6,362.1% in the first quarter. BlackRock Inc. now owns 5,939,352 shares of the medical instruments supplier’s stock valued at $226,229,000 after buying an additional 5,847,442 shares during the period. Vanguard Group Inc. boosted its position in Halyard Health by 4.7% in the first quarter. Vanguard Group Inc. now owns 4,350,518 shares of the medical instruments supplier’s stock valued at $165,711,000 after buying an additional 196,367 shares during the period. Dimensional Fund Advisors LP boosted its position in Halyard Health by 18.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,625,156 shares of the medical instruments supplier’s stock valued at $99,992,000 after buying an additional 415,105 shares during the period. State Street Corp boosted its position in Halyard Health by 1.8% in the first quarter. State Street Corp now owns 1,583,269 shares of the medical instruments supplier’s stock valued at $60,306,000 after buying an additional 28,718 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in Halyard Health by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 885,238 shares of the medical instruments supplier’s stock valued at $34,772,000 after buying an additional 3,596 shares during the period. Hedge funds and other institutional investors own 90.28% of the company’s stock.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.